AMICUS THERAPEUTICS, INC. — Director's Dealing 2015

Mar 27, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2015-03-25

Reporting Person: Do Hung (Sr Vice President Discovery)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-03-25	Common stock	D	41441	$10.8421	Disposed	787399	Direct

Footnotes

F1: The sales of shares of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 5, 2014.

F2: This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $10.59 to $11.28. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.